Coronary artery stents

JAMA

Volumn 284, Issue 14, 2000, Pages 1828-1836

  Al Suwaidi, Jassim ^a   Berger, Peter B ^a   Holmes, David R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; TICLOPIDINE; WARFARIN;

ACUTE HEART INFARCTION; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG INDUCED DISEASE; EVIDENCE BASED MEDICINE; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVASCULAR ULTRASOUND; MEDICAL LITERATURE; METHODOLOGY; PRIORITY JOURNAL; RESTENOSIS; SAFETY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0034638441     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.284.14.1828     Document Type: Article

References (154)

1. American College of Cardiology Expert Consensus documents: Coronary artery stents
2. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
3. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
4. Interventional cardiology and intracoronary stents - A changing practice
5. ACC Expert Consensus document on coronary artery stents
6. Randomized trial of PARAGON stent versus JJIS stent
7. Final results of the randomized Wallstent endoprosthesis in saphenous vein graft trial
8. Small vessel stenting: Six month results from the EXTRA Trial
9. Coronary artery stenting reduces restenosis: Final results from the Trial of Angioplasty and Stents in Canada (TASC) 1
10. Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START)
11. One-year follow-up of the Stent Restenosis (STRESS 1) Study
12. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease
13. Continued benefit of coronary stenting versus balloon angioplasty
14. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery
15. Optimal coronary balloon angioplasty with provisional stenting versus primary stent (OCBAS)
16. The Wallstent In Native coronary arteries (WIN) multi-center randomized trial
17. Balloon angioplasty vs Stent Study (BOSS)
18. The EPISTENT Investigators. Randomised placebo-controlled and balloon - Angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
19. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors
20. Highlights of the 48th scientific sessions of the American College of Cardiology
21. Prognostic value of the modified American College of Cardiology/American Heart Association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement
22. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting
23. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy
24. Accumulation of macrophages in the arterial vessel wall following experimental balloon angioplasty
25. Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration
26. Mechanisms of restenosis and redilation within coronary stents
27. Characteristics of an ideal stent based upon restenosis pathology
28. Long-term analysis of conventional coronary balloon angioplasty and an initial 'stent-like' result
29. Does angiography six months after coronary intervention influence management and outcome?
30. Angiographic follow-up after successful percutaneous coronary angioplasty for chronic total coronary occlusion
31. Percutaneous transluminal coronary angioplasty of chronic total occlusions
32. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions
33. Stenting in Chronic Coronary Occlusion (SICCO)
34. A randomized trial of elective stenting after balloon recanalization of chronic total occlusions
35. Stent implantation versus balloon angioplasty in chronic coronary occlusions
36. The CORSICA trial: Short and mid-term outcome
37. The STOP study: A randomized multicenter Israeli study for stents in total occlusion and restenosis prevention
38. Primary stenting versus balloon angioplasty in occluded coronary arteries: The Total Occlusion Study of Canada (TOSCA)
39. Coronary stenting following successful angioplasty for total occlusions
40. Stent or angioplasty after recanalization of chronic coronary occlusions?
41. Mayo-Japan Investigation for Chronic total occlusions (MAJIC)
42. Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts
43. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention
44. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts
45. Percutaneous transluminal coronary angioplasty in patients with prior coronary artery bypass grafting
46. Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years
47. Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting
48. Palmaz-Schatz stenting for treatment of focal vein graft stenosis
49. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts
50. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty
51. Trial Investigators. Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction
52. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial)
53. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction
54. Quantitative angiographic analysis of restenosis of primary s-tenting using Wiktor stent for acute myocardial infarction
55. Stentim 2 Investigators. STENTIM 2: Elective Wiktor stent implantation in acute myocardial infarction compared with balloon angiopiasty
56. Follow-up of the PSAAMI study population (Primary Stenting versus Angioplasty in Acute Myocardial Infarction)
57. Stent implantation for acute myocardial infarction
58. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction
59. Coronary angioplasty with or without stent implantation for acute myocardial infarction
60. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty
61. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angloplasty
62. Clinical and angiographic outcome of elective stent implantation in small coronary vessels
63. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries: Stent Restenosis Study (STRESS) Investigators
64. Safety and efficacy of angiography - Guided stent placement in small native coronary arteries of <3.0 mm in diameter
65. Vessel size and long-term outcome after coronary stent placement
66. Angiographic and clinical outcome following coronary stenting of small vessels
67. Intracoronary stenting in the treatment of acute or threatened closure in angiographically small coronary arteries (<3.0 mm) complicating percutaneous transluminal coronary angioplasty
68. Stenting small coronary arteries
69. The BESMART (Bestent in Small ARTeries) Study
70. A randomized comparison of elective stenting and balloon angioplasty in the treatment of small coronary arteries
71. Small native coronary vessel stenting
72. Bail-out stenting in small vessels
73. Primary stenting of de novo lesions in small coronary arteries
74. Immediate and one-year outcome of coronary stent implantation in small coronary vessels using 2.5 mm stents
75. Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stents
76. Acute and late outcome after use of 2.5-mm intracoronary stents in small (<2.5 mm) coronary arteries
77. Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000
78. The SISA study: A randomized comparison of balloon angioplasty and stent to prevent restenosis in small arteries
79. Restenosis after coronary angioplasty
80. Emergency coronary stenting for dissection during percutaneous transluminal coronary angioplasty
81. Predictors of restenosis after coronary stent implantation
82. Stented segment length as an independent predictor of restenosis
83. Left main coronary angioplasty
84. Results of percutaneous transluminal angioplasty of the left main coronary artery
85. 'High-risk' percutaneous transluminal coronary angioplasty
86. Percutaneous treatment of protected and unprotected left main coronary stenoses with new devices
87. Contemporary percutaneous treatment of unprotected left main coronary stenoses
88. Stenting of unprotected left main coronary artery stenoses
89. A prospective study of elective stenting in unprotected left main coronary disease
90. Trousers-Stents: How to choose the right size and shape
91. Is birfurcation stenting the answer?
92. Immediate and long term outcome of intracoronary stent implantation for true bifurcation lesions
93. Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin
94. Bifurctaion lesions: Two stents versus one stent: Immediate and follow-up results
95. DEBATE II: Final results of the 6-month follow-up
96. Doppler-guided and QCA-guided aggressive PTCA has same target lesion revascularization of stent implantation
97. The French Randomized Optimal Stenting Trial
98. A randomized comparison of antipiatelet and anticoagulant therapy after the placement of coronary-artery stents
99. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting
100. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement
101. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting
102. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients
103. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation
104. Thrombotic thrombocytopenic purpura associated with ticlopidine
105. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
106. Thrombotic thrombocytopenic purpura associated with clopidogrel
107. Efficacy of ticlopidine and clopidogrel on the rate of cardiac events after stent implantation: Evidence from CLASSICS
108. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents
109. Ticlid or Plavix Post-Stents (TOPPS)
110. Clopidogrel versus tidopidine after intracoronary stent placement
111. Effectiveness of dopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation
112. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting
113. Short term mortality lower with clopidogrel than ticlopidine following coronary artery stenting
114. A comparison of clopidogrel to ticlopidine therapy for the prevention of major adverse cardiac events at thirty days and six months following coronary stent implantation
115. The use of clopidogrel instead of ticlopidine after intracoronary stent insertions
116. Use of a monoclonal antibody directed against the platelet giycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
117. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascuiarization
118. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina
119. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance
120. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy
121. Impact of intravascular ultrasound guidance in stent deployment on 6-month restenosis rate
122. Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents
123. Relation between target vessel revascularization and minimum stent area by intravascular ultrasound (CRUISE trial)
124. Instent restenosis
125. Angiographic patterns of in-stent restenosis
126. Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis
127. Treatment of in-stent restenosis with excimer laser coronary angioplasty
128. Laser angioplasty of restenosed coronary stents: Results of a multicenter surveillance trial
129. High-speed rotational ablation for in-stent restenosis
130. Mechanical debulking versus balloon angioplasty for the treatment of diffuse in-stent restenosis
131. Angioplasty versus rotational atherectomy for treatment of diffuse instent restenosis
132. Mechanisms and results of additional stent implantation to treat focal in-stent restenosis
133. Stenting for restenosis of stented lesions
134. In-stent restenosis: Should we stent the stent?
135. Stenting for in-stent restenosis
136. Catheter-based radiotherapy to inhibit restenosis after coronary stenting
137. Three-year clinical and angiographic follow-up after intracoronary radiation
138. Biocompatibility aspects of new stent technology
139. Pure beta-particle-emitting stents inhibit neointima formation in rabbits
140. Effects of endovascular radiation from a beta-particle-emitting stent in a porcine coronary restenosis model
141. Methods to improve dose uniformity for radioactive stents in endovascular brachy-therapy
142. Short-term (1 month) results of the dose response IRIS feasibility study of a beta-particle emitting radioisotope stent
143. Follow-up angiographic comparison of the low dose vs high dose phosphorus-32 radioactive isostent
144. 32P radioactive beta-emitting stent implantation in patients with coronary artery disease
145. Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan
146. One-year clinical outcomes and relative costs of primary infarct artery stenting versus angioplasty following systemic thrombolysis for acute myocardial infarcbon
147. Acute and long-term cost implications of coronary stenting
148. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery
149. Antiproliferative stent coatings
150. Local drug delivery